ZA916058B - Novel 1,4-dihydropyridine derivatives - Google Patents

Novel 1,4-dihydropyridine derivatives

Info

Publication number
ZA916058B
ZA916058B ZA916058A ZA916058A ZA916058B ZA 916058 B ZA916058 B ZA 916058B ZA 916058 A ZA916058 A ZA 916058A ZA 916058 A ZA916058 A ZA 916058A ZA 916058 B ZA916058 B ZA 916058B
Authority
ZA
South Africa
Prior art keywords
novel
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
ZA916058A
Other languages
English (en)
Inventor
Jan Geert Sterk
Geert Sterk Jan
Jan Fetze Van Der Werf
Fetze Van Der Werf Jan
Hendrik Timmerman
Timmerman Hendrik
Jan Bron
Bron Jan
Original Assignee
Cedona Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedona Pharm Bv filed Critical Cedona Pharm Bv
Publication of ZA916058B publication Critical patent/ZA916058B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA916058A 1990-08-02 1991-08-01 Novel 1,4-dihydropyridine derivatives ZA916058B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9001752A NL9001752A (nl) 1990-08-02 1990-08-02 Nieuwe 1,4-dihydropyridinederivaten.

Publications (1)

Publication Number Publication Date
ZA916058B true ZA916058B (en) 1992-06-24

Family

ID=19857506

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916058A ZA916058B (en) 1990-08-02 1991-08-01 Novel 1,4-dihydropyridine derivatives

Country Status (13)

Country Link
US (1) US5378718A (xx)
EP (1) EP0541634A1 (xx)
JP (1) JPH05509094A (xx)
AU (1) AU655192B2 (xx)
CA (1) CA2088251A1 (xx)
FI (1) FI930429A (xx)
IE (1) IE912754A1 (xx)
IL (1) IL99030A0 (xx)
NL (1) NL9001752A (xx)
NO (1) NO180084C (xx)
NZ (1) NZ239234A (xx)
WO (1) WO1992002503A1 (xx)
ZA (1) ZA916058B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8142794A (en) * 1993-11-17 1995-06-06 Byk Nederland Bv Use of substituted 1,4-dihydropyridine to reduce intraocular pressure
EP1108710A4 (en) * 1998-07-23 2001-11-21 Chen Ing Jun GUAIACOXYPROPANOLAMINE WITH ALPHA / BETA ADRENERGIC INHIBIT ACTIVITY
SE0301010D0 (sv) * 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
PL2797416T3 (pl) 2011-12-28 2017-12-29 Global Blood Therapeutics, Inc. Podstawione związki benzaldehydowe i sposoby ich zastosowania do zwiększania natlenienia tkanek
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR20190041548A (ko) 2013-03-15 2019-04-22 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
MY191087A (en) 2013-03-15 2022-05-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201591426A1 (ru) 2013-03-15 2016-02-29 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
WO2014145040A1 (en) * 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
BR112015032160B1 (pt) 2014-02-07 2021-11-30 Global Blood Therapeutics, Inc Ansolvato cristalino de composto, composição e composição farmacêutica
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
TWI752307B (zh) 2016-05-12 2022-01-11 美商全球血液治療公司 新穎化合物及製造化合物之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives
JPS58185562A (ja) * 1982-04-22 1983-10-29 Taisho Pharmaceut Co Ltd １，４−ジヒドロピリジン誘導体
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS6289662A (ja) * 1985-06-14 1987-04-24 Sankyo Co Ltd １，４−ジヒドロピリジン誘導体
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
AU1153088A (en) * 1986-12-24 1988-07-27 Boehringer Biochemia Robin S.P.A New aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them
DE3833893A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte
DE3833892A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
JPH05509094A (ja) 1993-12-16
AU8280191A (en) 1992-03-02
CA2088251A1 (en) 1992-02-03
EP0541634A1 (en) 1993-05-19
NO180084C (no) 1997-02-12
NO930306L (no) 1993-01-29
US5378718A (en) 1995-01-03
NL9001752A (nl) 1992-03-02
AU655192B2 (en) 1994-12-08
IE912754A1 (en) 1992-02-12
NZ239234A (en) 1994-06-27
IL99030A0 (en) 1992-07-15
NO180084B (no) 1996-11-04
WO1992002503A1 (en) 1992-02-20
FI930429A0 (fi) 1993-02-01
FI930429A (fi) 1993-02-01
NO930306D0 (no) 1993-01-29

Similar Documents

Publication Publication Date Title
HU9202848D0 (en) 1,2-dihydro-2-oxopyridine
ZA916058B (en) Novel 1,4-dihydropyridine derivatives
EP0569493A4 (en) Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
GB2260135B (en) Substituted 2,6-diaminotoluenes
ZA916905B (en) 1,2,5,6-tetrahydropyridine oxine derivatives
EP0474129A3 (en) 1,4-dihydropyridine derivatives and process for preparing the same
EP0391187A3 (en) Substituted 4-amino-5-alkylthio-1,2,4-triazol-3-ones
ZA917516B (en) Substituted 5-alkoxy-1,2,4-triazol-3-(thi)ones
EP0460418A3 (en) Novel dihydropyridine derivative
EP0481950A3 (en) 1,4-dideoxy-4-fluoronojirimycin
EP0482206A4 (en) 4,6-o-hydroxyphosphorylglucosamine derivative
HU908313D0 (en) New 15-nitro-2betha, 3betha-dihydro- and 15-nitro-2betha, 3 betha,6,7-tetrahydro-tabersonine derivatives
HU9301651D0 (en) Pyridyl-1,2,5-oxadiazole-carbonamide-2-oxide derivatives
ZA90301B (en) 8,9-annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
DE3461086D1 (en) 1,4-dihydropyridine derivatives
JPS6431780A (en) 1,4-dihydropyridine derivative
JPS6431781A (en) 1,4-dihydropyridine derivative
ZA925184B (en) 3,4-dehydropiperidine derivatives
GB9026256D0 (en) Hexahydroazepine derivatives
HU210820A9 (en) 1,2,3,6-tetrahydropyridine derivatives
GB8906324D0 (en) 1,4-dihydropyridines
HU908254D0 (en) New piperidine- and 1,2,3,6-tetrahydro-pyridine derivatives
IE900167L (en) 8,9-ANNELATED-1,2,3,4-TETRAHYDRO-ß-CARBOLINE DERIVATIVES
EP0444276A3 (en) 1,2,4-triazolyl-propanol derivatives
IE901509L (en) 1,5-benzothiazepin derivatives